Trachisan 8 mg pastile Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

trachisan 8 mg pastile

engelhard - lidokainijev klorid - pastila - lidokainijev klorid 8 mg / 1 pastilalidokainijev klorid monohidrat - lidokain

Versatis 700 mg zdravilni obliž Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

versatis 700 mg zdravilni obliž

gruenenthal gmbh - lidokain - zdravilni obliž - lidokain 700 mg / 1 obliž - lidokain

Versatis 700 mg zdravilni obliž Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

versatis 700 mg zdravilni obliž

gruenenthal gmbh - lidokain - zdravilni obliž - lidokain 700 mg / 1 obliž - lidokain

Xylocaine 20 mg/ml raztopina za injiciranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

xylocaine 20 mg/ml raztopina za injiciranje

astrazeneca uk limited - lidokainijev klorid - raztopina za injiciranje - lidokainijev klorid 20 mg / 1 ml - lidokain

Thyrogen Evropska unija - slovenščina - EMA (European Medicines Agency)

thyrogen

sanofi b.v. - tirotropin alfa - Širokopasemske neoplazme - spodnjega režnja hipofize hormoni in analogi, hipofize in hypothalamic hormoni in analogi - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.